Cargando…
Emergence and onward transmission of a SARS-CoV-2 E484K variant among household contacts of a bamlanivimab-treated patient
The implementation of monoclonal antibody therapeutics during the COVID-19 pandemic altered the selective pressures encountered by SARS-CoV-2, raising the possibility of selection for resistant variants. Within-host viral evolution was reported in treated immunocompromised individuals but whether th...
Autores principales: | Sabin, Arick P., Richmond, Craig S., Kenny, Paraic A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810429/ https://www.ncbi.nlm.nih.gov/pubmed/35231807 http://dx.doi.org/10.1016/j.diagmicrobio.2022.115656 |
Ejemplares similares
-
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany
por: Jensen, Bjoern, et al.
Publicado: (2021) -
Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021) -
SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household
por: Yi, Seonju, et al.
Publicado: (2021) -
Émergence de variants E484 K suite à une monothérapie bamlanivimab chez des patients COVID-19 à haut risque d’évolution vers une forme sévère
por: Peiffer-Smadja, N., et al.
Publicado: (2021) -
Optimized infection control practices augment the robust protective effect of vaccination for ESRD patients during a hemodialysis facility SARS-CoV-2 outbreak
por: Meller, Megan E., et al.
Publicado: (2022)